Key result
Patients with STEMI had higher serum levels of uric acid and hs-CRP compared to individuals with NSTE ACS.
Why the study?
ACS is correlated with systemic inflammatory responses and biochemical factors, prompting investigation into serum CRP and uric acid levels to distinguish between STEMI and NSTE ACS.
Do serum levels of hs-CRP and uric acid distinguish STEMI from NSTE ACS?
Observational (n=140)
Do serum levels of hs-CRP and uric acid distinguish STEMI from NSTE ACS?
Answers are grounded in this paper and cite their sources.
Serum hs-CRP and uric acid levels are significantly higher in STEMI compared to NSTE ACS, suggesting their potential role as biomarkers for distinguishing these ACS subtypes.
Acute coronary syndrome (ACS) is defined as a range of conditions which the blood flow to the heart was reduced or stopped. This disorder is correlated to a systemic inflammatory response and some biochemical factors. Therefore, the aim of this study was investigations of serum C-reactive protein (CRP) and uric acid levels in ST-segment elevation myocardial infarction (STEMI) and non-ST-elevation ACS (NSTE ACS), as common subtypes of ACS. Patients with ACS (n = 140) were assessed with coronary arteriography and divided into STEMI and NSTE ACS groups. The serum levels of hs-CRP and uric acid were investigated using a routine clinical chemistry analyzer. Patients with STEMI showed a significant increase in uric acid level compared to those with NSTE ACS (P < .0001). Other data indicated that hs-CRP level in patients with STEMI was significantly higher than individuals with NSTE ACS (P < .0001). Modeling analysis revealed that the increased levels of acid uric and hs-CRP in patients with STEMI were independent of the effects of age, gender, background diseases, and familial history (P < .001). The current study provides further evidence to indicate that hs-CRP and uric acid may be considered as biofactors for comparing STEMI from NSTE ACS and determining disease outcome.
No takes yet. Share an insight, caveat, or question.
Zamani et al. (2022) conducted an observational in Acute coronary syndrome (STEMI and NSTE ACS) (n=140). STEMI vs. NSTE ACS was evaluated on Serum levels of hs-CRP and uric acid (p=<.0001). Patients with STEMI had higher serum levels of uric acid and hs-CRP compared to individuals with NSTE ACS.
Synapse has enriched 10 related papers. Consider them for comparative context: